PNC Financial Services Group’s Adicet Bio ACET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-11
Closed -$162 4885
2024
Q4
$162 Hold
11
﹤0.01% 4668
2024
Q3
$242 Hold
11
﹤0.01% 4659
2024
Q2
$203 Hold
11
﹤0.01% 4665
2024
Q1
$395 Hold
11
﹤0.01% 4525
2023
Q4
$318 Sell
11
-77
-88% -$1.68K ﹤0.01% 4454
2023
Q3
$1.92K Hold
88
﹤0.01% 4254
2023
Q2
$3.4K Buy
+88
New +$7.77K ﹤0.01% 4217
2020
Q3
Sell
-1
Closed 3909
2020
Q2
$0 Hold
1
﹤0.01% 3896
2020
Q1
$0 Hold
1
﹤0.01% 3870
2019
Q4
$0 Hold
1
﹤0.01% 3960
2019
Q3
$2K Hold
1
﹤0.01% 3837
2019
Q2
$2K Hold
1
﹤0.01% 3846
2019
Q1
$2K Hold
1
﹤0.01% 3853
2018
Q4
$2K Hold
1
﹤0.01% 3834
2018
Q3
$2K Hold
1
﹤0.01% 3928
2018
Q2
$2K Hold
1
﹤0.01% 3965
2018
Q1
$2K Buy
+1
New +$1.83K ﹤0.01% 4015

Other funds holding ACET

PNC Financial Services Group's ACET Position: Q1 2025 in Review

PNC Financial Services Group sold out of Adicet Bio (ACET) in Q1 2025, closing a stake of 11 shares — an estimated $162 sold.

PNC Financial Services Group first reported a position in ACET in Q1 2018 and held it in 17 quarters. The position peaked at $3.4K in Q2 2023. 56 funds tracked by Wall St. Rank hold ACET as of Q1 2025.

  • PNC Financial Services Group reported no remaining Adicet Bio position as of Q1 2025 after selling out during the quarter.
  • PNC Financial Services Group sold 11 Adicet Bio shares in Q1 2025, an estimated $162.
  • PNC Financial Services Group first reported a position in Adicet Bio in Q1 2018 and held it in 17 quarters.
  • PNC Financial Services Group's Adicet Bio position peaked at $3.4K in Q2 2023.
  • 56 funds tracked by Wall St. Rank held Adicet Bio as of Q1 2025.

Based on PNC Financial Services Group's 13F filing for Q1 2025, filed 9 May 2025.